Connect
← Return to Distant recurrence risk
Discussion
Breast Cancer | Last Active: Aug 8, 2023 | Replies (23)
Comment receiving replies
Thank you for such detailed insight. My oncologist mentioned CYP2D6 to me and told me to contact my insurance myself to see if they will cover the test. I would think it’s her job to do that. She thinks based on my race I may not be able to metabolize it.
Replies to "Thank you for such detailed insight. My oncologist mentioned CYP2D6 to me and told me to..."
Connect
Hi @brighterdays, I had United Healthcare in 2013 and they covered the CYP2D6 test at that time, but again I have genetic mutations and that can make a difference. It might be worth calling your insurance provider to ask so you don't get stuck with a big bill. Let them know it would be to see if you can metabolize Tamoxifen because the test may only be covered for certain drugs. Yes, I do think your oncologist could offer better customer service and check for you. I hadn't heard of anything race related so I googled and get conflicting data on that. I didn't see any real alarm bells for any race, but google that yourself to see what you find. I did read only 5% of the general population is a CYP2D6 poor metabolizer, but again google and see what you find. You also don't want to be an ultrarapid metabolizer. You want to be a normal metabolizer. Don't we all just want to be normal? Normal is underrated. 🙂 Best of luck to you.